Acid Sphingomyelinase Deficiency (Niemann-Pick Disease) Market Focus 2015 - PowerPoint PPT Presentation

View by Category
About This Presentation
Title:

Acid Sphingomyelinase Deficiency (Niemann-Pick Disease) Market Focus 2015

Description:

This report provides comprehensive information on the therapeutic development for Acid Sphingomyelinase Deficiency (Niemann-Pick Disease), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Acid Sphingomyelinase Deficiency (Niemann-Pick Disease) and special features on late-stage and discontinued projects. Enquiry @ – PowerPoint PPT presentation

Number of Views:38

less

Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: Acid Sphingomyelinase Deficiency (Niemann-Pick Disease) Market Focus 2015


1
Acid Sphingomyelinase Deficiency (Niemann-Pick
Disease)Pipeline Review, H2 2015
No. Pages 61
Published on October - 2015
2
.
Report Overview
About Acid Sphingomyelinase Deficiency
(Niemann-Pick Disease) Pipeline Review, H2
2015 Research Beam added report on Acid
Sphingomyelinase Deficiency (Niemann-Pick
Disease) Pipeline Review, H2 2015.
Summary Global Markets Directs, Acid
Sphingomyelinase Deficiency (Niemann-Pick
Disease) Pipeline Review, H2 2015, provides an
overview of the Acid Sphingomyelinase Deficiency
(Niemann-Pick Disease) s therapeutic pipeline.
This report provides comprehensive information on
the therapeutic development for Acid
Sphingomyelinase Deficiency (Niemann-Pick
Disease) , complete with comparative analysis at
various stages, therapeutics assessment by drug
target, mechanism of action (MoA), route of
administration (RoA) and molecule type, along
with latest updates, and featured news and press
releases. It also reviews key players involved in
the therapeutic development for Acid
Sphingomyelinase Deficiency (Niemann-Pick
Disease) and special features on late-stage and
discontinued projects. Get Full Details On
http//www.researchbeam.com/acid-sphingomyelinase-
deficiency-niemann-pick-disease-pipeline-review-h2
-2015-market
3
.
Report Overview
Global Markets Directs report features
investigational drugs from across globe covering
over 20 therapy areas and nearly 3,000
indications. The report is built using data and
information sourced from Global Markets Directs
proprietary databases, Company/University
websites, SEC filings, investor presentations and
featured press releases from company/university
sites and industry-specific third party sources,
put together by Global Markets Directs team. Drug
profiles/records featured in the report undergoes
periodic updation following a stringent set of
processes that ensures that all the profiles are
updated with the latest set of information.
Additionally, processes including live news
deals tracking, browser based alert-box and
clinical trials registries tracking ensure that
the most recent developments are captured on a
real time basis. The report enhances decision
making capabilities and help to create effective
counter strategies to gain competitive advantage.
It strengthens RD pipelines by identifying new
targets and MOAs to produce first-in-class and
best-in-class products. Note Certain sections
in the report may be removed or altered based on
the availability and relevance of data for the
indicated disease.  
4
.
Report Overview
Scope The report provides a snapshot of the
global therapeutic landscape of Acid
Sphingomyelinase Deficiency (Niemann-Pick
Disease) The report reviews key pipeline
products under drug profile section which
includes, product description, MoA and RD brief,
licensing and collaboration details other
developmental activities The report reviews key
players involved in the therapeutics development
for Acid Sphingomyelinase Deficiency
(Niemann-Pick Disease) and enlists all their
major and minor projects The report summarizes
all the dormant and discontinued pipeline
projects A review of the Acid Sphingomyelinase
Deficiency (Niemann-Pick Disease) products under
development by companies and universities/research
institutes based on information derived from
company and industry-specific sources Pipeline
products coverage based on various stages of
development ranging from pre-registration till
discovery and undisclosed stages. A detailed
assessment of monotherapy and combination therapy
pipeline projects Coverage of the Acid
Sphingomyelinase Deficiency (Niemann-Pick
Disease) pipeline on the basis of target, MoA,
route of administration and molecule type  
5
Report Overview
Reasons to buy  Provides strategically
significant competitor information, analysis, and
insights to formulate effective RD development
strategies Identify emerging players with
potentially strong product portfolio and create
effective counter-strategies to gain competitive
advantage Develop strategic initiatives by
understanding the focus areas of leading
companies Identify and understand important and
diverse types of therapeutics under development
for Acid Sphingomyelinase Deficiency
(Niemann-Pick Disease) Plan mergers and
acquisitions effectively by identifying key
players of the most promising pipeline Devise
corrective measures for pipeline projects by
understanding Acid Sphingomyelinase Deficiency
(Niemann-Pick Disease) pipeline depth and focus
of Indication therapeutics Develop and design
in-licensing and out-licensing strategies by
identifying prospective partners with the most
attractive projects to enhance and expand
business potential and Scope Modify the
therapeutic portfolio by identifying discontinued
projects and understanding the factors that drove
them from pipeline  
6
Table Of Contents
List of Tables 5List of Figures 5Introduction
6Global Markets Direct Report Coverage 6Acid
Sphingomyelinase Deficiency (Niemann-Pick
Disease) Overview 7Therapeutics Development
8Pipeline Products for Acid Sphingomyelinase
Deficiency (Niemann-Pick Disease) - Overview
8Pipeline Products for Acid Sphingomyelinase
Deficiency (Niemann-Pick Disease) - Comparative
Analysis 9Acid Sphingomyelinase Deficiency
(Niemann-Pick Disease) - Therapeutics under
Development by Companies 10Acid Sphingomyelinase
Deficiency (Niemann-Pick Disease) - Therapeutics
under Investigation by Universities/Institutes 11
7
Table Of Contents
Acid Sphingomyelinase Deficiency (Niemann-Pick
Disease) - Pipeline Products Glance 12Clinical
Stage Products 12Early Stage Products 13Acid
Sphingomyelinase Deficiency (Niemann-Pick
Disease) - Products under Development by
Companies 14Acid Sphingomyelinase Deficiency
(Niemann-Pick Disease) - Products under
Investigation by Universities/Institutes 15Acid
Sphingomyelinase Deficiency (Niemann-Pick
Disease) - Companies Involved in Therapeutics
Development 16Genzyme Corporation 16La Jolla
Pharmaceutical Company 17Merck Co., Inc.
18Okklo Life Sciences BV 19Orphazyme ApS 20
8
Table Of Contents
Acid Sphingomyelinase Deficiency (Niemann-Pick
Disease) - Therapeutics Assessment 21 Assessment
by Monotherapy Products 21Assessment by Target
22Assessment by Mechanism of Action
24Assessment by Route of Administration
26Assessment by Molecule Type 28   Enquiry
about this report _at_ http//www.researchbeam.com/ac
id-sphingomyelinase-deficiency-niemann-pick-diseas
e-pipeline-review-h2-2015-market/enquire-about-rep
ort
9
FOR MORE DETAILS
Visit us at
http//www.researchbeam.com/acid-sphingomyelinase-
deficiency-niemann-pick-disease-pipeline-review-h2
-2015-market
Stay With Us
5933 NE Win Sivers Drive,205, Portland, OR
97220United States
TELEPHONE 1 (800) 910-6452 E-MAIL
sales_at_researchbeam.com
About PowerShow.com